Standout Papers

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in... 2003 2026 2010 2018 2.1k
  1. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer (2003)
    Mark G. Kris, Ronald B. Natale et al. JAMA

Immediate Impact

2 by Nobel laureates 24 from Science/Nature 196 standout
Sub-graph 1 of 9

Citing Papers

Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
103 intermediate papers

Works of T. J. Lynch being referenced

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout

Author Peers

Author Last Decade Papers Cites
T. J. Lynch 49 70 5 1726 1635 18 2.2k
Xiuyu Julie Cong 20 1270 1211 19 1.7k
Christopher Lau 30 36 991 762 23 1.6k
Leonard P. James 5 36 1041 1040 29 2.7k
Masaharu Nomura 14 1230 840 36 1.9k
Victoria A. Joshi 1 10 2121 1823 28 3.0k
Lynne D. Berry 1 16 1048 915 33 1.8k
Orit Freedman 2 65 1224 1496 40 2.2k
Tien Hoang 13 1410 1740 65 2.3k
Meghan J. Mooradian 19 1145 1702 67 2.5k
Maria Toki 5 33 379 1027 32 1.6k

All Works

Loading papers...

Rankless by CCL
2026